Molecular dynamic simulations analysis of ritronavir and lopinavir as SARS-CoV 3CL(pro) inhibitors

Since the emergence of the severe acute respiratory syndrome (SARS) to date, neither an effective antiviral drug nor a vaccine against SARS is available. However, it was found that a mixture of two HIV-1 proteinase inhibitors, lopinavir and ritonavir, exhibited some signs of effectiveness against th...

Descripción completa

Detalles Bibliográficos
Autores principales: Nukoolkarn, Veena, Lee, Vannajan Sanghiran, Malaisree, Maturos, Aruksakulwong, Ornjira, Hannongbua, Supot
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2008
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094092/
https://www.ncbi.nlm.nih.gov/pubmed/18706430
http://dx.doi.org/10.1016/j.jtbi.2008.07.030

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094092/
https://www.ncbi.nlm.nih.gov/pubmed/18706430
http://dx.doi.org/10.1016/j.jtbi.2008.07.030

Ejemplares similares